Patents by Inventor John McNeil McGill

John McNeil McGill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide
    Patent number: 8552039
    Abstract: The present invention relates to novel compounds, methods, and formulations useful for the oral delivery of a GLP-1 compound or an MC4 agonist peptide.
    Type: Grant
    Filed: December 11, 2009
    Date of Patent: October 8, 2013
    Assignee: Emisphere Technologies, Inc.
    Inventors: Robert Jason Herr, Louis Nickolaus Jungheim, John McNeil McGill, Kenneth Jeff Thrasher, Muralikrishna Valluri
  • METHOD FOR ADMINISTERING GLP-1 MOLECULES
    Publication number: 20110178006
    Abstract: The invention relates to formulations that demonstrate the feasibility of oral absorption comprising glucose-like peptide-1 compounds and specified delivery agents, and to methods of stimulating GLP-1 receptor in a subject in need of such stimulation, by administration of the formulation of the present invention.
    Type: Application
    Filed: January 12, 2011
    Publication date: July 21, 2011
    Applicant: Emisphere Technologies, Inc.
    Inventors: Mohommed Amin KHAN, Bryan Edward Jones, John McNeil McGill